Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy

Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition)

(2014) Mototsugu Oya et al.   INTERNATIONAL JOURNAL OF UROLOGY

Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma

(2013) Enrico Munari et al.   HUMAN PATHOLOGY

The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma

(2012) Y. Miyazaki et al.   CLINICAL CANCER RESEARCH

A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer

(2012) L. S. Rosen et al.   CLINICAL CANCER RESEARCH

Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy

(2012) Kazutoshi Fujita et al.   INTERNATIONAL JOURNAL OF UROLOGY

Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins

(2012) David A. Green et al.   JOURNAL OF UROLOGY

Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis

(2011) William Dubinski et al.   HUMAN PATHOLOGY

Angiotensin II Type 1 Receptor Expression and Microvessel Density in Human Bladder Cancer

(2011) Suguru Shirotake et al.   UROLOGY

Role of Tumor Suppressor and Angiogenesis Markers in Prediction of Recurrence of Non Muscle Invasive Bladder Cancer

(2010) Usha Agrawal et al.   PATHOLOGY & ONCOLOGY RESEARCH

Expression of endoglin (CD105) in cervical cancer

(2009) H J Zijlmans et al.   BRITISH JOURNAL OF CANCER

Endoglin (CD105) as a urinary and serum marker of prostate cancer

(2008) Kazutoshi Fujita et al.   INTERNATIONAL JOURNAL OF CANCER